Purchase Order 75N92019P00429

This is a $3,654.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Arraystar Inc. for "OTHER FUNCTIONS MICROARRAY SERVICE". Arraystar Inc. is a for-profit company that specializes in innovative tools and sample to data services for non-coding RNA research, including long non-coding RNAs (LncRNAs), microRNAs, circular RNAs, and transfer RNAs. This...

<p>The National Heart Lung and Blood Institute issued a purchase order to Georgetown University on July 24, 2017, for an Agilent Mouse Gene Expression V2 4x44K microarray (Catalog G4846A) valued at $4,050.00 under firm fixed pricing. Work is performed in Washington, DC 20057. The order is not set-aside and carries an ultimate completion date of August 31, 2017.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $13,804.00 on October 29, 2020, for TruSeq Stranded RNA Core LP Box 2 kits to prepare RNA sequencing libraries for genomic analysis. Work was performed in San Diego, California. The order, firm fixed-price with no set-aside designation, was completed by November 30, 2020.</p>

The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for $116,928.00 on June 22, 2026, to supply Infinium Methylation Screening Array-48 kits for an epigenome-wide association study of cardiovascular disease mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Work is performed in San Diego, California. The order carries a firm fixed-price structure with an ultimate completion date of June 21, 2027. No set-aside designation applies.

<p>The National Heart Lung and Blood Institute issued a $4,480.82 delivery order to Illumina, Inc. on January 24, 2015, with ultimate completion by August 31, 2015.</p> <p>Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside designation.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for $122,257.00 on February 14, 2017 for scientific equipment, with ultimate completion by March 16, 2017. Place of performance is Bethesda, Maryland. No set-aside applied. The order is firm fixed price.</p>

<p>The National Heart Lung and Blood Institute issued an $18,364.45 delivery order to Illumina, Inc. on July 28, 2017, for lab supplies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of August 16, 2017. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Reprocell U.S.A., Inc. for DNA and RNA extraction from whole blood with a ceiling value of $73,338.90, effective April 15, 2020, and completing April 14, 2021. Work is performed at Calverton, Maryland. The order is firm fixed price with no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for a nanopore direct RNA sequencing system valued at $50,105.35 on August 19, 2020. The system is to be delivered to Bethesda, Maryland. Work is firm fixed price with an ultimate completion date of August 21, 2020. The purchase order originated from a special notice posted August 7, 2020, and carried no small business set-aside.</p>

<p>The National Heart Lung and Blood Institute issued a $18,909 delivery order to Illumina, Inc. on November 14, 2014, with an ultimate completion date of August 31, 2015. Place of performance is Bethesda, MD. The order is firm fixed price with no set-aside applied. The source does not identify the parent vehicle name or vehicle type under which this delivery order was issued.</p>